Logo

antibiotic resistance

Curetis to Assist BioVersys' Antibacterial Drug Trial With Unyvero Platform

BioVersys will use the Unyvero HPN in its drug trial to test hospitalized trial candidates for antibiotic-resistant Acinetobacter infections.

Day Zero Diagnostics Secures Additional $8.2M From CARB-X

The funding will support product development for Day Zero's whole-genome sequencing and machine learning-based diagnostic.

T2 Biosystems Reports Preliminary Drop in Q2 Revenues, Cuts Workforce

The firm is reducing its expenses by cutting 34 existing and 20 planned positions.

 

BioMérieux, Boehringer Ingelheim, Evotec Launch €40M AMR-Targeted Joint Venture

Called Aurobac Therapeutics, the joint venture will develop new antimicrobial drugs and companion diagnostics.

OpGen Unyvero Pneumonia Panel Helps Curb Inappropriate Antibiotic Use in Prospective Trial
Premium

The company expects the trial results to bolster sales by increasing physician confidence in the panel.

Jun 9, 2022

Curetis, Leader Life Sciences Partner to Distribute Unyvero in UAE and Qatar

Feb 23, 2022

OpGen Looks to Ramp up Clinical Use of Acuitas AMR Gene Panel in Wake of FDA Clearance
Premium

Feb 11, 2022

Machine Learning May Extend MALDI Mass Spec-Based Antibiotic Resistance Testing
Premium

Feb 9, 2022

Day Zero Diagnostics Closes $21M VC Financing Round

Jan 10, 2022

MALDI-TOF Mass Spec Approach Can Predict Antimicrobial Resistance in Clinical Samples

Sep 7, 2021

CSIRO Develops Software to Detect Foreign DNA Without Reference Genomes
Premium

May 26, 2021

Torus Biosystems Completes $25M Series A Financing Round

May 7, 2021

T2 Biosystems Advancing Pipeline, Accelerating Instrument Placement Strategy
Premium

Mar 23, 2021

After Winning XPrize, ChromaCode Sets Sights on SARS-CoV-2 Testing Expansion
Premium

Mar 18, 2021

SpeeDx Inks Distribution Deal for Infectious Disease Tests in Turkey

Mar 15, 2021

Roche to Acquire GenMark Diagnostics for $1.8B

Mar 1, 2021

Host DNA Methylation Signatures May Predict Likelihood of Persistent, Resolving MRSA Infections

Feb 24, 2021

LexaGene Open-Access Syndromic Panel Platform Lets Labs Customize Targets, Including SARS-CoV-2
Premium

Feb 18, 2021

E. Coli Metabolic Gene Mutations Implicated in Antibiotic Resistance

Jan 13, 2021

OpGen Preliminary Q4 Revenue Climbs 63 Percent

Nov 11, 2020

OpGen Posts 70 Percent Increase in Q3 Revenues Amid Shuffling of Portfolio

Oct 23, 2020

ICBiome Bets on Whole-Genome Sequencing Analysis to Control MRSA, COVID-19 Outbreaks
Premium

Oct 14, 2020

OpGen Provides Additional Info to FDA on Antimicrobial Resistance Gene Panel

Oct 8, 2020

Genomic Data Helps Explain Yaws Re-emergence, Antibiotic Resistance in Papua New Guinea

Sep 30, 2020

BARDA Exercises $10.5M Option on T2 Bio Contract

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.